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A b s trac t
A patient with Schnitzler’s syndrome is described presenting with fever of unknown origin. Although he had all 
characteristic features of the syndrome (urticarial vasculitis, hyperostosis, lymphadenopathy, fever and serum IgM 
monoclonal component), it was recognized very late in the diagnostic process. Cytokines were measured to get more insight 
into the role of cytokines in this syndrome, but only interleukin-6 was elevated. It is important for internists and 
rheumatologist to recognize this entity in order to prevent unnecessary diagnostic procedures. © 1997 Elsevier Science B.Y.
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1. Introduction
Urticarial vasculitis can be secondary to many 
diseases causing fever of unknown origin (FUO, i.e., 
systemic lupus erythematosus and other connective 
tissue diseases, helminthic infections, hepatitis B, 
infectious mononucleosis, malignancies, thyroid dis­
eases and hypocomplementaemia with renal diseases
t u .
In 1974 Schnitzler et al. [2] reported 5 patients 
with urticarial vasculitis together with hyperostosis,
Abbreviations: FUO — fever of unknown origin; IL-1 — 
interleukin-1; TNFa — tumour necrosis factor-a; IL-6 = 
interleukin-1; IFNg = interferon-gamma; IL-lra = interleukin-1 
receptor antagonist
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lymphadenopathy, fever and serum IgM monoclonal 
component. Even after extensive diagnostic workup 
no underlying cause was found and it appeared to be 
a specific entity. Schnitzler’s syndrome has since 
been described in 28 cases, mostly in French [3-7]. 
Fever is an important feature of the syndrome and 
cases can be wrongly labeled as FUO. In computer- 
aided literature databases like MEDLINE (Medline 
National Library of Medicine, Bethesda, MD) this 
entity cannot be found using ‘fever of unknown 
origin’ as a key word. However, it is important to 
recognize this syndrome as a cause of FUO, in order 
to prevent unnecessary diagnostic procedures.
In this case report, we present a patient with 
Schnitzler’s syndrome, with fever as a prominent 
symptom leading to many unnecessary investigations 
in several hospitals, before recognition of the syn­
drome .
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2. Case report
A 72-year-old man was referred to our department 
for a second opinion because of fever of 1 year 
duration. Despite extensive diagnostic workup in two 
other university hospitals no diagnosis had been 
established. His medical history revealed bronchial 
asthma and eczema. The patient also had urticaria for 
approximately 1 year, which became pruritic 3 
months before referral to our hospital. Body tempera­
tures were remittent and hectic with a difference of 
3-4°C between peak and trough, and he complained 
about night sweating, fatigue and pain in both upper 
legs. He had received up to 40 mg of prednisone 
until a few months before, without any improvement. 
At the time of referral, only slightly swollen cervical 
lymph nodes were present. The urticarial lesions 
were located on trunk and extremities. No arthritis or 
splenomegaly was evident. Laboratory data were 
significant for elevated erythrocyte sedimentation rate 
(79 mm/h), C-reactive protein (84 mg/1), micro­
cytic anaemia of chronic disease (5.2 mmol/1) and 
hypoalbuminaemia. Cryoglobulin and circulating im­
mune complexes were absent, serology for hepatitis 
C was negative and complement profile was normal. 
Immunoelectrophoretic analysis identified a serum 
monoclonal IgM (6.5 m g /1). Blood for cytokine 
measurement was drawn once during fever, Circulat­
ing TNFa was 80 pg/ml (normal, < 120 pg/ml), 
IL-ip 70 pg/m l (normal, < 65 pg/m l) and IL-lra 
330 pg/m l (normal, < 490 pg/ml), measured by 
RIA as described elsewhere [8]. Circulating IFNg 
was <  6 pg/m l (normal, < 6 pg/m l) and IL-6 74 
pg/m l (normal, < 3 pg/ml), measured by ELISA 
as described elsewhere [8], Whole blood in-vitro 
stimulation assays were performed on TNFa, IL-lp, 
IL-6 and IL-lra as described elsewhere and were all 
normal. Biopsy of an urticarial lesion showed urticar­
ial vasculitis without depositions in the immunofluo­
rescence. Bone marrow biopsy and lymph node 
biopsy were unremarkable, showing polyclonal plas- 
macytosis, with normal distribution of immuno­
globulin and light chains, without domination of 
IgM-positive cells. An X-ray of the right femur 
showed hyperostosis of the right femur, whereas 
scintigraphic imaging was unremarkable. Multiple 
cultures of blood, urine and sputum were all nega­
tive. Because of these symptoms, we concluded that
the patient suffered from Schnitzler’s syndrome and 
started colchicine therapy. The fever and urticaria 
became less but did not disappear. Remission of 
symptoms was obtained only after addition of pred­
nisone (15 mg) and naproxen (500 mg twice a day). 
Our patient has now had a free follow-up of 24 
months.
3. Discussion
Our patient presented for a second opinion be­
cause of FUO. Schnitzler’s syndrome was not diag­
nosed by many previously consulted internists. A 
review of the literature on Schnitzler’s syndrome 
showed that most patients appear to share the pres­
ence of chronic, usually non-pruritic urticaria, recur­
rent fever, lymphadenopathy, monoclonal serum IgM 
and hyperostosis with bone pain. The prognosis is 
generally good, but long-term follow-up is advisable 
since 3 of the 28 reported cases developed a malig­
nancy: Waldenstrom’s macroglobulinaemia, lympho- 
plasmocytic lymphoma and angio-immunoblastic 
lymphadenopathy (AILD) [6]. Our patient was exam­
ined in several hospitals and underwent an extensive 
diagnostic program, which could have been pre­
vented by the recognition of the syndrome. Because 
of the presence of monoclonal IgM it will still be 
necessary to perform a bone marrow biopsy in this 
category of patients. A possible pitfall remains the 
fact that AILD was found after a long follow-up in 
one patient with Schnitzler’s syndrome. It is some­
times difficult to establish this diagnosis and several 
lymph node biopsies may be necessary.
To get more insight into the role of cytokines in 
the systemic features of Schnitzler’s syndrome we 
measured cytokines in our patient. Despite the fever 
there were no increased circulating concentrations of 
known endogenous pyrogens such as TNFa and 
IL-1(3. IL-6 was slightly elevated in our patient, 
which would imply that IL-6 plays a role in some of 
the systemic features of the syndrome. Indeed, IL-6 
is a major modulator of the acute phase reaction 
characterized by fever, leukocytosis, increased vas­
cular permeability and elevation of acute phase pro­
tein [9].
To date, the pathophysiological mechanism of this 
syndrome has not yet been clarified. IgM and IgG
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antibodies against interleukin-lot (IL-la) have been 
shown in serum and human epidermis [10], which 
would imply a pathophysiological role for IL-1 in 
the systemic features of this syndrome. However, the 
physiological role of circulating auto-antibodies is 
not clear at all, because auto-antibodies (mostly of 
the IgG but sometimes also IgM) are detectable in 
24% of apparently normal adults [11].
No specific therapy for patients with Schnitzler’s 
syndrome is available. Systemic corticosteroids are 
first choice in therapy, NSAID’s are also used suc­
cessfully [4], Colchicine also appeal's to be effective 
[12] and often, as in our patient, a combination is 
necessary to suppress symptoms.
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